Related Experiment Video
Updated: May 19, 2026
08:56
Synthesis of a Borylated Ibuprofen Derivative Through Suzuki Cross-Coupling and Alkene Boracarboxylation Reactions
Published on: November 30, 2022
Need to develop new nonsteroidal anti-inflammatory drug formulations
Bill McCarberg1, Allan Gibofsky
1Neighborhood Healthcare, Escondido, California, USA. drknowpain@cox.net
Clinical Therapeutics
|September 4, 2012
Summary
Nonsteroidal anti-inflammatory drugs (NSAIDs) are common pain relievers but carry risks. New NSAID formulations are needed to improve safety and tolerability while maintaining pain relief efficacy.
Area of Science:
- Pain management
- Pharmacology
- Drug safety
Background:
- Primary care physicians manage acute and chronic pain.
- Nonsteroidal anti-inflammatory drugs (NSAIDs) are widely used for pain relief.
- Safety and tolerability of NSAIDs remain a concern for patients and clinicians.
Purpose of the Study:
- Review unmet needs in pain management.
- Examine dose-dependent NSAID safety data.
- Discuss the need for improved NSAID formulations for safety and efficacy.
Main Methods:
- Literature search of PubMed and Cochrane Library databases.
- Focused on English articles reporting NSAID dose-dependent safety and tolerability.
- Data search concluded in December 2012.
Main Results:
- NSAIDs are associated with dose-dependent risks to the GI tract, cardiovascular system, and kidneys.
- FDA mandated updated NSAID labeling regarding cardiovascular and GI bleeding risks.
- Lower NSAID doses reduce adverse events but may compromise efficacy.
Conclusions:
- New NSAID formulations are required.
- Improved formulations should address safety and tolerability concerns.
- Efficacy in pain and inflammation management must be maintained.
Related Concept Videos
01:11Oral Drug Delivery Systems: Delayed-Release Systems
Delayed-release drug delivery systems are specialized pharmaceutical formulations designed to postpone the release of active compounds until the drug reaches a specific region of the gastrointestinal (GI) tract, typically the intestine. These systems are essential for drugs that may cause gastric irritation, are unstable in acidic environments, or need to exert therapeutic effects locally in the intestinal or colonic regions.The core feature of delayed-release systems is the use of enteric...
01:27Drug Delivery Systems: Different Types
Conventional oral drug products, termed immediate-release (IR) formulations, are engineered to promptly release their active pharmaceutical ingredient (API) upon ingestion, typically in tablets or capsules. This rapid release often results in swift drug absorption and consequent pharmacodynamic effects, although the timing and intensity can vary depending on the drug's properties. Prodrugs within these formulations require metabolic conversion to activate their pharmacodynamic effects,...
01:19Modified-Release Drug Delivery Systems: Overview
Modified-release dosage forms are designed to address the limitations of drugs with short biological half-lives. These forms maintain stable therapeutic drug concentrations over extended periods, reducing the need for frequent dosing. A consistent drug level helps minimize peak-trough fluctuations, which can reduce adverse effects, lower the risk of drug resistance, and improve overall treatment effectiveness.One common type of modified-release form is the extended-release (ER) formulation. ER...
01:27Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...
01:23Oral Drug Delivery Systems: Introduction
Oral drug delivery is the most common route of administration due to its convenience, cost-effectiveness, and high patient compliance. It enables precise formulation to ensure proper drug dosage and bioavailability. The development of oral dosage forms considers drug properties such as solubility, stability, and absorption to optimize therapeutic efficacy.Tablets, capsules, liquids, and chewable formulations enhance drug stability, mask undesirable tastes, and improve patient experience.
01:26Oral Drug Delivery Systems: Continuous-Release Systems
Continuous-release drug delivery systems offer a strategic approach to maintaining therapeutic drug levels over extended periods following oral administration. By modulating the release rate of active pharmaceutical ingredients, these systems minimize fluctuations in plasma concentrations, which enhances clinical efficacy and reduces the need for frequent dosing. Such characteristics make them particularly advantageous in managing chronic diseases where patient adherence and stable drug...